Ameresco Likely to See 'Downside Risk' to 2025 Adjusted EBITDA Guidance Amid Federal Contract Risks, UBS Says

MT Newswires Live
03-05

Ameresco's (AMRC) 2025 adjusted earnings before interest, taxes, depreciation, and amortization guidance is likely to be lower than expected, driven by potential deterioration in federal contracts under the Trump administration's streamlining efforts, UBS said Tuesday.

UBS said it sees "downside risk" to 2025 adjusted EBITDA guidance, as well as "further downward" revisions for 2026 to 2027 consensus estimates. The firm said its 2026-2027 adjusted EBITDA estimates are now 11% below Street estimates.

"In our view, the Trump administration is still in the early stages of efforts to streamline the Federal government and while the ultimate outcome is unclear, we believe a further deterioration in the contracting environment for [Ameresco's] federal projects (20-30% of revenue) is highly probable," UBS said.

While Ameresco's stable earnings stream remains attractive within the brokerage's Clean Energy coverage, heightened federal uncertainty makes the risk/reward balance unfavorable, according to the note.

UBS downgraded its rating on Ameresco to sell from buy and lowered its price target to $8 from $37.

Shares of Ameresco were down 5.4% in recent Tuesday trading.

Price: 10.00, Change: -0.57, Percent Change: -5.35

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10